Lynda D Lisabeth1,2, Brisa N Sánchez3, David Lim3, Ronald D Chervin4, Erin Case1, Lewis B Morgenstern1,2, Susan Tower5, Devin L Brown2. 1. Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI. 2. Stroke Program, University of Michigan Health System, Ann Arbor, MI. 3. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI. 4. Michael S. Aldrich Sleep Disorders Laboratory, University of Michigan Health System, Ann Arbor, MI. 5. local physician, Corpus Christi, TX.
Abstract
OBJECTIVE: To examine the association between sleep-disordered breathing and stroke outcomes, and determine the contribution of sleep-disordered breathing to outcome disparities in Mexican Americans. METHODS: Ischemic stroke patients (n = 995), identified from the population-based Brain Attack Surveillance in Corpus Christi Project (2010-2015), were offered participation in a sleep-disordered breathing study including a home sleep apnea test (ApneaLink Plus). Sleep-disordered breathing (respiratory event index ≥10) was determined soon after stroke. Neurologic, functional, cognitive, and quality of life outcomes were assessed at 90 days poststroke. Regression models were used to assess associations between sleep-disordered breathing and outcomes, adjusted for sociodemographics, prestroke function and cognition, health-risk behaviors, stroke severity, and vascular risk factors. RESULTS: Median age was 67 years (interquartile range [IQR] = 59-78); 62.1% were Mexican American. Median respiratory event index was 14 (IQR = 6-25); 62.8% had sleep-disordered breathing. Sleep-disordered breathing was associated with worse functional outcome (mean difference in activities of daily living/instrumental activities of daily living score = 0.15, 95% confidence interval [CI] = 0.01-0.28) and cognitive outcome (mean difference in modified Mini-Mental State Examination = -2.66, 95% CI = -4.85 to -0.47) but not neurologic or quality of life outcomes. Sleep-disordered breathing accounted for 9 to 10% of ethnic differences in functional and cognitive outcome and was associated with cognitive outcome more strongly for Mexican Americans (β = -3.97, 95% CI = -6.63 to -1.31) than non-Hispanic whites (β = -0.40, 95% CI = -4.18 to 3.39, p-interaction = 0.15). INTERPRETATION: Sleep-disordered breathing is associated with worse functional and cognitive function at 90 days poststroke. These outcomes are reasonable endpoints for future trials of sleep-disordered breathing treatment in stroke. If effective, sleep-disordered breathing treatment may somewhat lessen ethnic stroke outcome disparities. ANN NEUROL 2019;86:241-250.
OBJECTIVE: To examine the association between sleep-disordered breathing and stroke outcomes, and determine the contribution of sleep-disordered breathing to outcome disparities in Mexican Americans. METHODS:Ischemic strokepatients (n = 995), identified from the population-based Brain Attack Surveillance in Corpus Christi Project (2010-2015), were offered participation in a sleep-disordered breathing study including a home sleep apnea test (ApneaLink Plus). Sleep-disordered breathing (respiratory event index ≥10) was determined soon after stroke. Neurologic, functional, cognitive, and quality of life outcomes were assessed at 90 days poststroke. Regression models were used to assess associations between sleep-disordered breathing and outcomes, adjusted for sociodemographics, prestroke function and cognition, health-risk behaviors, stroke severity, and vascular risk factors. RESULTS: Median age was 67 years (interquartile range [IQR] = 59-78); 62.1% were Mexican American. Median respiratory event index was 14 (IQR = 6-25); 62.8% had sleep-disordered breathing. Sleep-disordered breathing was associated with worse functional outcome (mean difference in activities of daily living/instrumental activities of daily living score = 0.15, 95% confidence interval [CI] = 0.01-0.28) and cognitive outcome (mean difference in modified Mini-Mental State Examination = -2.66, 95% CI = -4.85 to -0.47) but not neurologic or quality of life outcomes. Sleep-disordered breathing accounted for 9 to 10% of ethnic differences in functional and cognitive outcome and was associated with cognitive outcome more strongly for Mexican Americans (β = -3.97, 95% CI = -6.63 to -1.31) than non-Hispanic whites (β = -0.40, 95% CI = -4.18 to 3.39, p-interaction = 0.15). INTERPRETATION:Sleep-disordered breathing is associated with worse functional and cognitive function at 90 days poststroke. These outcomes are reasonable endpoints for future trials of sleep-disordered breathing treatment in stroke. If effective, sleep-disordered breathing treatment may somewhat lessen ethnic stroke outcome disparities. ANN NEUROL 2019;86:241-250.
Authors: Xiaqing Jiang; Lewis B Morgenstern; Christine T Cigolle; Lu Wang; Edward S Claflin; Lynda D Lisabeth Journal: Stroke Date: 2021-09-14 Impact factor: 7.914
Authors: Sandeep P Khot; Heather M Barnett; Arielle P Davis; Eeeseung Byun; Barbara S McCann; Charles H Bombardier; Korren Rappisi; W T Longstreth; Martha E Billings; Devin L Brown; Michelle M Garrison Journal: Sleep Med Date: 2022-05-26 Impact factor: 4.842
Authors: Benjamin K Petrie; Tudor Sturzoiu; Julie Shulman; Saleh Abbas; Hesham Masoud; Jose Rafael Romero; Tatiana Filina; Thanh N Nguyen; Helena Lau; Judith Clark; Sanford Auerbach; Yelena G Pyatkevich; Hugo J Aparicio Journal: J Clin Med Date: 2021-08-13 Impact factor: 4.241
Authors: Sonja G Schütz; Lynda D Lisabeth; River Gibbs; Xu Shi; Ronald D Chervin; Madeline Kwicklis; Erin Case; Devin L Brown Journal: J Am Heart Assoc Date: 2022-02-12 Impact factor: 6.106
Authors: C Bernasconi; S R Ott; F Fanfulla; S Miano; T Horvath; A Seiler; C W Cereda; A-K Brill; P Young; L Nobili; M Manconi; C L A Bassetti Journal: Sleep Med X Date: 2020-10-09